International Reviews of Immunology

Papers
(The TQCC of International Reviews of Immunology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Regulatory Effects of Clock and Bmal1 on Circadian Rhythmic TLR Expression105
Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting95
Combining the past and present to advance immuno-radiotherapy of cancer52
Breaking the graft-versus-host-disease barrier: Mesenchymal stromal/stem cells as precision healers51
Chemokines: A key driver for inflammation in protozoan infection36
The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies34
Immunological and biological dissection of normal and tumoral salivary glands29
T cell receptor revision and immune repertoire changes in autoimmune diseases22
CAR-T cells for cancer immunotherapy—the barriers ahead and the paths through20
Exploring the role of neutrophils in infectious and noninfectious pulmonary disorders20
An insight into COVID-19 host immunity at single-cell resolution18
Epigenetic regulation of T cell development18
Molecular mechanisms of ferroptosis and their role in inflammation17
The NLRP3 inflammasome: Mechanisms of activation, regulation, and role in diseases17
Th17 cells: A new target in kidney disease research17
Role of thymus in health and disease15
Immunological processes of enhancers and suppressors of long non-coding RNAs associated with brain tumors and inflammation14
Retraction13
Research progress on the role and mechanism of action of exosomes in autoimmune thyroid disease13
MDSCs interactions with other immune cells and their role in maternal-fetal tolerance12
Gut microbiome as a treatment in colorectal cancer11
B7-H3-targeted CAR-T cell therapy for solid tumors11
Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy11
Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia9
Dimensions of inflammation in host defense and diseases9
The role of TRIM59 in immunity and immune-related diseases9
Next generation strategies to recover immunological tolerance in celiac disease9
FUNDC1 mediated mitochondria-dependent ferroptosis of epithelial cells in model of asthma by FBXL2/ar/GPX4 signaling pathway of SUMO1 at K1369
0.24135613441467